Chris Watt

In his role as Chief Financial Officer, Chris Watt oversees Quiver's accounting, treasury, reporting, and FP&A functions with over 30 years of financial and operational experience. Most recently, Chris served as Senior Vice President & Head of Finance at Tetraphase Pharmaceuticals where he helped raise over $150 million in capital, drove successful launch of the company’s first approved product, and helped lead the eventual sale of the company to La Jolla Pharmaceuticals. Prior to Tetraphase, he spent almost 11 years at Biogen, Inc. in various financial leadership roles, including Senior Director and Finance Lead for the company’s global commercial business. Chris has also worked in various financial and operational leadership roles at InterSystems Corporation, Putnam Investments, Procter & Gamble and Shawmut National Corporation. Chris holds a B.A. in economics and German from Colby College and an M.B.A. from the University of Michigan.